Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 13.19 is 15% below its 5-year average of 15.43, near the low end of its 5-year range (10.39–26.75).
As of the fiscal period ended Tuesday, June 30, 2026. 11.41% below its 12-month average of 14.88.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.19.
CURRENT RATIO
13.19
CURRENT RATIO AVG TTM
14.88
CURRENT RATIO AVG 3Y
14.43
CURRENT RATIO AVG 5Y
15.43
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-11.41%
CURRENT VS 3Y AVG
-8.64%
CURRENT VS 5Y AVG
-14.57%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+251.63%
vs the sector median at left
ORIC Pharmaceuticals, Inc.
Market Cap
$1.22B
Current Ratio
13.19
TTM Avg
14.88
3Y Avg
14.43
5Y Avg
15.43
Market Cap
$1.20B
Current Ratio
14.91
TTM Avg
19.24
3Y Avg
24.35
5Y Avg
31.62
Market Cap
$1.17B
Current Ratio
19.73
TTM Avg
13.53
3Y Avg
9.78
5Y Avg
15.63
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ORIC Pharmaceuticals, Inc. (ORIC) | $1.22B | 13.19 | 14.88 | 14.43 | 15.43 |
| Cronos Group Inc. (CRON)vs › | $1.22B | 16.18 | 19.21 | 18.77 | 16.93 |
| Innovage Holding Corp. (INNV)vs › | $1.21B | 1.05 | 1.06 | 1.16 | 1.68 |
| Omada Health (OMDA)vs › | $1.23B | 3.91 | 2.85 | 3.60 | 3.60 |
| Tyra Biosciences, Inc. (TYRA)vs › | $1.20B | 14.91 | 19.24 | 24.35 | 31.62 |
| MannKind Corporation (MNKD)vs › | $1.20B | 1.72 | 2.49 | 3.01 | 2.95 |
| Kardigan, Inc. (KARD)vs › | $1.26B | 8.72 | 9.20 | 9.20 | 9.20 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | 19.73 | 13.53 | 9.78 | 15.63 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.13B | 1.38 | 3.96 | 6.78 | 9.79 |
| Nektar Therapeutics (NKTR)vs › | $1.13B | 10.42 | 4.62 | 5.92 | 7.14 |
Current Ratio
13.19
Quick Ratio
13.19
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 13.19 |
| 2026-03-31 | 16.33 |
| 2025-12-31 | 14.13 |
| 2025-09-30 | 14.65 |
| 2025-06-30 | 16.13 |
| 2025-03-31 | 12.00 |
| 2024-12-31 | 10.56 |
| 2024-09-30 | 13.15 |
| 2024-06-30 | 15.08 |
| 2024-03-31 | 21.31 |
| 2023-12-31 | 10.39 |
| 2023-09-30 | 12.26 |
| 2023-06-30 | 18.46 |
| 2023-03-31 | 12.99 |
| 2022-12-31 | 13.68 |
| 2022-09-30 | 14.96 |
| 2022-06-30 | 18.72 |
| 2022-03-31 | 20.23 |
| 2021-12-31 | 15.87 |
| 2021-09-30 | 24.60 |
| 2021-06-30 | 26.75 |
| 2021-03-31 | 36.49 |
| 2020-12-31 | 32.96 |
| 2020-09-30 | 27.29 |
| 2020-06-30 | 34.48 |
| 2020-03-31 | 16.78 |
| 2019-12-31 | 16.81 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
